Stay Up to Date
with SHINE

NS Energy covers SHINE in "Why commercial fusion is already here to stay."

Proponents see a reduction in the need for uranium mining and more efficient, cheaper reactors. Opponents see a risk of proliferation.

Nuclear NewsWire features SHINE in "The road to wellness: The task of getting lifesaving medical isotopes to patients."

Janesville, WI - SHINE Technologies will exhibit at the 2024 SNMMI Mid-Winter and ACNM Annual Meeting taking place February 1-3 in Orlando, FL. SHINE invites attendees to visit Booth #12 to learn about the company's production supply capabilities for non-carrier-added lutetium-177 (n.c.a Lu-177) at its Cassiopeia facility. 

A year of progress and promise. Join us to dive into SHINE's top ten moments of 2023- A Year of Progress and Promise

From wearables to new forces of nature these are the top 7 innovation news of 2023 that you need to know. Click to read the coverage

Our CEO and Founder, Greg Piefer was featured on an episode of Breakthrough Economies by Nasdaq. Check out the interview

The New Yorker covers Paul Ryan's affiliation with SHINE Technologies

WisBusiness shares Greg Piefer's Podcast Interview. Click here to listen now

SHINE Technologies proudly announces the appointment of three distinguished board members, Ray Rothrock, Sue Marks, and Gordon Gunnlaugsson, bringing a wealth of expertise to further advance its mission in nuclear fusion technology and radioisotope production.

DRUG Discovery & Development: 50 of the best-funded biotechs of 2023

Genetic Engineering & Biotechnology News Covers SHINE Partnership with Nucleus RadioPharma

Genetic Engineering and Biotechnology News covers SHINE Technologies and Nucleus RadioPharma's partnership.

WisBusiness covers SHINE Technologies new supplier agreement with Nucleus RadioPharma.

NuclearNewswire covers recent trade agreement with Nucleus RadioPharma to receive lu-177 under agreement with SHINE Technologies.